Cite

HARVARD Citation

    Yamazaki, K. et al. (2020). Budget impact analysis of treatment‐free remission in nilotinib‐treated Japanese chronic myeloid leukemia patients. Cancer science. 111 (7), pp. 2526-2535. [Online]. 
  
Back to record